575 POSTER Targeting metastatic tumor cell functions by inhibition of new blood vessel formation with the selective VEGF signal inhibitor, cediranib (RECENTIN™, AZD2171) or Src signaling interference using the small molecule Src inhibitor, AZD0530
D.W. Siemann, M. DongVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72509-6
File:
PDF, 73 KB
english, 2008